The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.
Advertisement
The Scientist
Most Recent
When general practitioner John Lusingu returned to his native Tanzania to do research on malaria, he was met with a total lack of science infrastructure. Undeterred, he helped convert a former kitchen in the Korogwe District Hospital into a small mal
FDA points its finger at an early-stage contract research organization for falsifying documents and manipulating samples.
As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.
A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.
Mice with miniature human livers more accurately test a drug’s toxic side effects.
Researchers find that an ingredient in common cough medicine improves multiple sclerosis symptoms in animal models.
South Korea approves the first stem-cell medication for clinical use.
How cognitive prejudices can influence research decisions, and how the pitfalls of human nature can be avoided
A male hormone-blocker currently used to treat prostate cancer may also benefit breast cancer patients.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
